TRCT
ORKA

Tower Research Capital (TRC)’s Oruka Therapeutics ORKA Stock Holding History

Tower Research Capital (TRC)’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$169K Buy
3,449
+2,954
+597% +$103K ﹤0.01% 1747
2025
Q4 		$15K Sell
495
-1,723
-78% -$48K ﹤0.01% 3314
2025
Q3 		$42.7K Sell
2,218
-131
-6% -$1.94K ﹤0.01% 2657
2025
Q2 		$26.3K Buy
2,349
+1,595
+212% +$16.6K ﹤0.01% 3514
2025
Q1 		$7.74K Buy
754
+170
+29% +$2.12K ﹤0.01% 3936
2024
Q4 		$11.3K Sell
584
-381
-39% -$9.29K ﹤0.01% 3727
2024
Q3 		$23.7K Buy
965
+936
+3,228% +$32.6K ﹤0.01% 3147
2024
Q2 		$1.32K Sell
29
-227
-89% -$9.05K ﹤0.01% 5172
2024
Q1 		$5.41K Buy
256
+4
+2% +$80 ﹤0.01% 4546
2023
Q4 		$5.14K Sell
252
-56
-18% -$1.26K ﹤0.01% 4876
2023
Q3 		$7.42K Buy
308
+104
+51% +$2.55K ﹤0.01% 4469
2023
Q2 		$4.96K Sell
204
-45
-18% -$1.11K ﹤0.01% 4882
2023
Q1 		$6K Buy
249
+126
+102% +$3.32K ﹤0.01% 4898
2022
Q4 		$3K Buy
123
+79
+180% +$2.02K ﹤0.01% 5255
2022
Q3 		$1K Buy
+44
New +$1.24K ﹤0.01% 5862
2022
Q2 		– Sell
-413
Closed -$11K – 6606
2022
Q1 		$11K Buy
413
+223
+117% +$5.53K ﹤0.01% 4224
2021
Q4 		$5K Sell
190
-5
-3% -$151 ﹤0.01% 5206
2021
Q3 		$7K Buy
195
+189
+3,150% +$6.99K ﹤0.01% 4685
2021
Q2 		$0 Sell
6
-1,299
-100% -$54.2K ﹤0.01% 5910
2021
Q1 		$57K Buy
+1,305
New +$68.5K ﹤0.01% 3014
2020
Q4 		– Sell
-13
Closed -$1K – 5460
2020
Q3 		$1K Buy
+13
New +$917 ﹤0.01% 4745
2020
Q1 		– Hold
0
– – – 4044
2019
Q4 		– Hold
0
– – – 4500
2016
Q4 		– Sell
-2
Closed -$1K – 4485
2016
Q3 		$1K Buy
2
+1
+100% +$644 ﹤0.01% 3390
2016
Q2 		$1K Sell
1
-3
-75% -$2.22K ﹤0.01% 4234
2016
Q1 		$3K Buy
4
+3
+300% +$2.44K ﹤0.01% 3182
2015
Q4 		$1K Sell
1
-38
-97% -$43K ﹤0.01% 4190
2015
Q3 		$42K Buy
+39
New +$59.4K ﹤0.01% 1149
2014
Q4 		– Sell
-1
Closed -$2K – 4782
2014
Q3 		$2K Buy
+1
New +$2.09K ﹤0.01% 3889
2014
Q2 		– Sell
-3
Closed -$6.98K – 4723
2014
Q1 		$8K Sell
3
-7
-70% -$20.5K ﹤0.01% 2861
2013
Q4 		$25K Buy
+10
New +$23.1K ﹤0.01% 2083
2013
Q3 		– Sell
-2
Closed -$5K – 4895
2013
Q2 		$5K Buy
+2
New +$6.11K ﹤0.01% 2970

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Tower Research Capital (TRC)'s ORKA Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Oruka Therapeutics (ORKA) stake by 597% in Q1 2026, buying an estimated $103K and bringing the position to 3,449 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #1747.

Tower Research Capital (TRC) first reported a position in ORKA in Q2 2013 and has held it in 30 quarters since. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • Tower Research Capital (TRC) held 3,449 shares of Oruka Therapeutics worth $169K as of Q1 2026.
  • Tower Research Capital (TRC) bought 2,954 Oruka Therapeutics shares in Q1 2026, an estimated $103K.
  • Oruka Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1747 holding.
  • Tower Research Capital (TRC) first reported a position in Oruka Therapeutics in Q2 2013 and has held it in 30 quarters since.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.